These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 3100340

  • 1. Thromboxane A2 biosynthesis in human disease.
    FitzGerald GA, Healy C, Daugherty J.
    Fed Proc; 1987 Jan; 46(1):154-8. PubMed ID: 3100340
    [Abstract] [Full Text] [Related]

  • 2. Increased thromboxane metabolites excretion in liver cirrhosis.
    Davì G, Ferro D, Basili S, Iuliano L, Camastra C, Giammarresi C, Santarone S, Rocca B, Landolfi R, Ciabattoni G, Cordova C, Violi F.
    Thromb Haemost; 1998 Apr; 79(4):747-51. PubMed ID: 9569186
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Fractional conversion of thromboxane A2 and B2 to urinary 2,3-dinor-thromboxane B2 and 11-dehydrothromboxane B2 in the cynomolgus monkey.
    Patrignani P, Morton H, Cirino M, Lord A, Charette L, Gillard J, Rokach J, Patrono C.
    Biochim Biophys Acta; 1989 Jul 21; 992(1):71-7. PubMed ID: 2752041
    [Abstract] [Full Text] [Related]

  • 6. Thromboxane and prostacyclin biosynthesis in patients with acute spontaneous intracerebral hemorrhage.
    Saloheimo P, Juvela S, Riutta A, Pyhtinen J, Hillbom M.
    Thromb Res; 2005 Jul 21; 115(5):367-73. PubMed ID: 15733969
    [Abstract] [Full Text] [Related]

  • 7. 11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation.
    Catella F, Healy D, Lawson JA, FitzGerald GA.
    Proc Natl Acad Sci U S A; 1986 Aug 21; 83(16):5861-5. PubMed ID: 3461463
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [11-Dehydro-TXB2 and 2,3-dinor-TXB2 as new parameters of TXA2 generation].
    Katori M, Kawamura M, Sawada M.
    Nihon Rinsho; 1992 Feb 21; 50(2):349-54. PubMed ID: 1613989
    [Abstract] [Full Text] [Related]

  • 10. Increased thromboxane biosynthesis in childhood hemolytic uremic syndrome.
    Tönshoff B, Momper R, Kühl PG, Schweer H, Schärer K, Seyberth HW.
    Kidney Int; 1990 Apr 21; 37(4):1134-41. PubMed ID: 2111418
    [Abstract] [Full Text] [Related]

  • 11. Thromboxane A(2) generation, in the absence of platelet COX-1 activity, in patients with and without atherothrombotic myocardial infarction.
    DeFilippis AP, Oloyede OS, Andrikopoulou E, Saenger AK, Palachuvattil JM, Fasoro YA, Guallar E, Blumenthal RS, Kickler TS, Jaffe AS, Gerstenblith G, Schulman SP, Rade JJ.
    Circ J; 2013 Apr 21; 77(11):2786-92. PubMed ID: 23985963
    [Abstract] [Full Text] [Related]

  • 12. Effect of anticardiolipin/beta2-glycoprotein I complexes on production of thromboxane A2 by platelets from patients with the antiphospholipid syndrome.
    Robbins DL, Leung S, Miller-Blair DJ, Ziboh V.
    J Rheumatol; 1998 Jan 21; 25(1):51-6. PubMed ID: 9458202
    [Abstract] [Full Text] [Related]

  • 13. Effect of the infusion of OKY-046, a thromboxane A2 synthase inhibitor, on urinary metabolites of prostacyclin and thromboxane A2 in healthy human subjects.
    Morio H, Hirai A, Terano T, Tamura Y, Yoshida S.
    Thromb Haemost; 1993 Mar 01; 69(3):276-81. PubMed ID: 8470052
    [Abstract] [Full Text] [Related]

  • 14. Increased thromboxane B2 excretion in diabetes mellitus.
    Katayama S, Inaba M, Maruno Y, Omoto A, Kawazu S, Ishii J.
    J Lab Clin Med; 1987 Jun 01; 109(6):711-7. PubMed ID: 3585144
    [Abstract] [Full Text] [Related]

  • 15. Increased platelet thromboxane synthesis in diabetes mellitus.
    Halushka PV, Rogers RC, Loadholt CB, Colwell JA.
    J Lab Clin Med; 1981 Jan 01; 97(1):87-96. PubMed ID: 7452084
    [Abstract] [Full Text] [Related]

  • 16. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
    Mehta J, Mehta P, Lawson DL, Ostrowski N, Brigmon L.
    J Lab Clin Med; 1985 Sep 01; 106(3):246-52. PubMed ID: 3928780
    [Abstract] [Full Text] [Related]

  • 17. Differential effects of dazoxiben, a selective thromboxane-synthase inhibitor, on platelet and renal prostaglandin-endoperoxide metabolism.
    Patrignani P, Filabozzi P, Catella F, Pugliese F, Patrono C.
    J Pharmacol Exp Ther; 1984 Feb 01; 228(2):472-7. PubMed ID: 6537977
    [Abstract] [Full Text] [Related]

  • 18. Urinary excretion and origin of 11-dehydro-2,3-dinor-thromboxane B2 in man.
    Chiabrando C, Rivoltella L, Alberti E, Bonollo M, Djurup R, Fanelli R.
    Prostaglandins; 1993 May 01; 45(5):401-11. PubMed ID: 8321910
    [Abstract] [Full Text] [Related]

  • 19. Increased thromboxane biosynthesis in essential thrombocythemia.
    Rocca B, Ciabattoni G, Tartaglione R, Cortelazzo S, Barbui T, Patrono C, Landolfi R.
    Thromb Haemost; 1995 Nov 01; 74(5):1225-30. PubMed ID: 8607099
    [Abstract] [Full Text] [Related]

  • 20. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation.
    Vezza R, Nenci GG, Gresele P.
    J Pharmacol Exp Ther; 1995 Dec 01; 275(3):1497-505. PubMed ID: 8531121
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.